Status:
COMPLETED
Persistent Opioid Consumption After Major Abdominal Surgery and Its Determinants
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsors:
Maisonneuve-Rosemont Hospital
Conditions:
Major Abdominal Surgery
Chronic Pain
Eligibility:
All Genders
18+ years
Brief Summary
The opioid crisis is a growing problem around the world, with prescription opioids being a major contributor to this crisis. They can be prescribed in different chronic and acute settings, such as sur...
Detailed Description
Objectives Primary objective: estimate the prevalence of POC 3 months after major abdominal surgery, describe its distribution in both opioid-naive and chronic opioid users and across different types...
Eligibility Criteria
Inclusion
- Patients undergoing major open abdominal surgery during the study period (6 months)
- Patients suffering from chronic pain or using opioids may be included since they are at risk of developing CPSP or POC
Exclusion
- Patients who have already participated in the study will be excluded as well as patients who will undergo a second surgery after discharge from hospital and before the 90-day deadline for the primary endpoint.
- Patients undergoing appendectomies, inguinal hernia repair and abdominal wall hernia repair other than incisional hernias.
Key Trial Info
Start Date :
February 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT05197465
Start Date
February 13 2022
End Date
September 30 2024
Last Update
February 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CIUSS-de-l'Est-de-l'Île-de-Montréal (Hôpital Maisonneuve-Rosemont)
Montreal, Quebec, Canada, H1T 2M4
2
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3E4